Literature DB >> 3318905

Experimental autoimmune glomerulonephritis in rats by soluble isologous or homologous antigens from glomerular and tubular basement membranes.

Y Sado1, I Naito.   

Abstract

Experimental autoimmune glomerulonephritis was induced in inbred WKY/NCrj rats and Wistar (closed colony) rats by a single injection of isologous or homologous soluble antigens from glomerular and tubular basement membranes. Glomerular and tubular basement membranes were trypsin digested and applied to an affinity column to which rabbit antibodies to bovine nephritogenic antigen had been coupled. The adsorbed fraction was nephritogenic when it was injected into rat footpads with Freund's complete adjuvant. Glomerulonephritis with long-lasting proteinuria and haematuria developed 2 to 3 weeks after the injection, and it was characterized histologically by endocapillary hypercellularity of mononuclear cells, capsular adhesion, sclerosis of capillary tufts, and crescent formation. Immunofluorescence study revealed the linear deposition of rat IgG along the glomerular basement membrane. Some rats with the nephritis had pulmonary hemorrhage. These results suggest that this experimental model is similar to the experimental glomerulonephritis induced in rats by bovine nephritogenic antigen, and to human anti-glomerular basement membrane antibody-induced glomerulonephritis including Goodpasture's syndrome.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318905      PMCID: PMC2013180     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  7 in total

1.  Experimental pulmonary disease and autoimmune nephritis in the rabbit produced by homologous and heterologous choroid plexus (experimental Goodpasture's syndrome).

Authors:  R M McIntosh; M N Koss; W B Chernack; W R Griswold; P B Copack; R Weil
Journal:  Proc Soc Exp Biol Med       Date:  1974-10

2.  The induction of acute glomerulonephritis in rabbits with soluble antigens isolated from normal homologous and autologous urine.

Authors:  R A Lerner; F J Dixon
Journal:  J Immunol       Date:  1968-06       Impact factor: 5.422

3.  A glycoprotein that induces nephrotoxic antibody: its isolation and purification from rat glomerular basement membrane.

Authors:  S Shibata; Y Miyakawa; T Naruse; T Nagasawa; T Takuma
Journal:  J Immunol       Date:  1969-03       Impact factor: 5.422

4.  Induction of chronic progressive glomerulonephritis with immunofluorescent "mesangial pattern" in rats.

Authors:  S Shibata; H Sakaguchi; T Nagasawa
Journal:  Nephron       Date:  1976       Impact factor: 2.847

5.  Experimental autoimmune glomerulonephritis with pulmonary hemorrhage in rats. The dose-effect relationship of the nephritogenic antigen from bovine glomerular basement membrane.

Authors:  Y Sado; T Okigaki; H Takamiya; S Seno
Journal:  J Clin Lab Immunol       Date:  1984-12

6.  Experimental allergic glomerulonephritis induced in the rabbit with heterologous renal antigens.

Authors:  E R Unanue; F J Dixon
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

7.  Experimental allergic glomerulonephritis induced in the rabbit with homologous renal antigens.

Authors:  E R Unanue; F J Dixon; J D Feldman
Journal:  J Exp Med       Date:  1967-01-01       Impact factor: 14.307

  7 in total
  3 in total

1.  Cyclosporin A in the prevention and treatment of experimental autoimmune glomerulonephritis in the brown Norway rat.

Authors:  J Reynolds; S J Cashman; D J Evans; C D Pusey
Journal:  Clin Exp Immunol       Date:  1991-07       Impact factor: 4.330

2.  CD28-B7 blockade prevents the development of experimental autoimmune glomerulonephritis.

Authors:  J Reynolds; F W Tam; A Chandraker; J Smith; A M Karkar; J Cross; R Peach; M H Sayegh; C D Pusey
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

3.  In vivo treatment with a monoclonal antibody to T helper cells in experimental autoimmune glomerulonephritis in the BN rat.

Authors:  J Reynolds; C D Pusey
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.